` PHX (Pharmx Technologies Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

P
PHX
vs
S
S&P/ASX 300

Over the past 12 months, PHX has significantly outperformed S&P/ASX 300, delivering a return of +73% compared to the S&P/ASX 300's +5% growth.

Stocks Performance
PHX vs S&P/ASX 300

Loading
PHX
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
PHX vs S&P/ASX 300

Loading
PHX
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
PHX vs S&P/ASX 300

Loading
PHX
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Pharmx Technologies Ltd vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Pharmx Technologies Ltd
Glance View

Market Cap
80.9m AUD
Industry
Technology

Pharmx Technologies Ltd is a AU-based company operating in Software industry. The company is headquartered in Sydney, New South Wales. PharmX Technologies Limited, formerly Corum Group Limited, is an Australian company that operates a network connecting retail pharmacies and suppliers in Australia and New Zealand. The firm offers PharmX, an electronic gateway that links pharmacies, pharmaceutical wholesalers and direct suppliers within the pharmacy market, and PharmXchange, a digital sales and marketing platform integrated with PharmX. The firm is also focused on creating a more productive environment for pharmacy and suppliers, with additional ordering functions, such as stock checks, credits, and auto account set up direct from their point of sale (POS) system.

PHX Intrinsic Value
0.025 AUD
Overvaluation 82%
Intrinsic Value
Price
P
Back to Top